glp-1 coupon Savings Offer Program for patients taking Wegovy (semaglutide) injection 2.4 mg CVS - Online Drugstore, Pharmacy,

people preferring to exhaust natural approaches before pharmaceutical intervention, viewing supplements as a first step in a progressive strategy

Tara *Based on internal survey 416 GLP-1 users in 2025 **Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program

ShedRx offers tirzepatide as a weekly injection only

Current consensus is that GLP-1 treatment benefits outweigh the risk of EWDR: the drugs reduce the risk of further microvascular damage from poor glycemic control and reduce the chance of death from cardiovascular disease, while the impact on DR is short-lived and can be treated